CDKN1A and metabolic dysfunction-associated steatotic liver disease: Therefore, the rs762623 in cyclin dependent kinase inhibitor 1A (CDKI1A) which encodes the cellular senescence marker p21, was significantly associated with disease progression in NAFLD [218].